+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Europe Pharmaceutical Continuous Manufacturing Market Forecast to 2027 - COVID-19 Impact and Regional Analysis By Product; Application; End User; and, Country- Product Image
Europe Pharmaceutical Continuous Manufacturing Market Forecast to 2027 - COVID-19 Impact and Regional Analysis By Product; Application; End User; and, Country- Product Image
Sale

Europe Pharmaceutical Continuous Manufacturing Market Forecast to 2027 - COVID-19 Impact and Regional Analysis By Product; Application; End User; and, Country

  • PDF Icon

    Report

  • 159 Pages
  • August 2020
  • Region: Europe
  • The Insight Partners
  • ID: 5147162
UP TO OFF until Jun 30th 2024
Description Jump to:
Europe pharmaceutical continuous manufacturing market is anticipated to reach US$ 799.50 million by 2027 from US$ 374.95 million in 2019. The market is projected to grow with a CAGR of 10.0% from 2019 to 2027.

The growth of the Europe pharmaceutical continuous manufacturing market is primarily attributed to the increasing shortage of medicines. However, high cost involved in drug manufacturing is likely to restrain the growth of the market in the coming years. On the other hand, strategic activities by the manufacturers are expected to have a positive impact on the growth of the Europe pharmaceutical continuous manufacturing market in the coming years.

Continuous manufacturing in the pharmaceutical industry is a result of advancements in technology with respect to the production techniques. The batch manufacturing method was traditionally followed in the pharmaceutical industry. However, the development in technology has accelerated mass production with improved quality, and it has addressed the many primary causes such as the recall of drugs and recalls. The pharmaceutical industry has recently begun to implement the continuous manufacturing process as an option to improve and sustain manufacturing operations.

More than 300 pharmaceutical continuous manufacturing companies are established in the regions such as Missouri, Columbia, Kansas, and Manhattan.

Shortage of essential medicines and drugs is the major drawback experienced by the global healthcare sector. This shortage is resulting into additional costs as well as risk to the patients’ health. The patients in need of medicines are failing to receive appropriate doses due to unavailability of medicines. According to the WHO Drug Information 2016, shortages of essential medicines have been reported from low, middle, and high-income countries. Medicine shortage poses risk for patient health as a result of non-treatment, under-treatment, and possible medication errors from attempts to substitute missing medicines. The Food and Drug Administration (FDA) states that the drug shortage occurs due to various reasons including quality problems, manufacturing inefficiency, and delays and discontinuations. The drugs that often fall short in supply include sterile injectable and oncology/cancer treatments. The notice from manufacturers to the FDA regarding the impending or current shortages of drugs allows the FDA to work with the manufacturers over finding feasible solutions, one of which is usually ramping up the manufacturing of drugs through implementation of new and advanced systems such as continuous manufacturing.

According to a report published by The Economist Intelligence Unit Limited in 2017, the prevalence of medicine shortage has been increased in Europe. The three major factors that determine the drug shortage are manufacturing, economic, and regulatory causes. Thus, in order to meet the rising demand for biologics and drugs, as well as to curb the lack of drug availability, pharmaceutical continuous manufacturing is a suitable solution that has to be implemented in the system.

Europe has been massively hit by the COVID-19 outbreak affecting many of its countries on a large scale. Italy, Germany, Spain, the UK, and France, are the major countries witnessing a rise in COVID-19 cases every day. As per data published by public sources, till March 26, Europe had an estimated 250,000 infected patients in the region. Also, the process of lockdown is expected to have a severe impact on new product launches and distributions. For instance, Comecer is headquartered in Italy with its factories in Italy and the Netherlands. Due to the lockdown and severe spread of COVID-19, the manufacturing process is strongly affected, which, in turn is hampering the growth of the continuous pharmaceutical manufacturing market.

In terms of product, the integrated systems segment accounted for the largest share of the Europe pharmaceutical continuous manufacturing market in 2019 and is estimated to mark the highest CAGR in the market during the forecast period, owing to the factors such as their easy availability and accessibility as well as higher adoption of these systems compared to the semi-continuous systems. Also, the convenience of use of upright freezers has led to its dominance during 2019 and is expected to witness similar trend over the coming years.

Centers For Disease Control And Prevention (CDC), Defense Research and Development Organization (DRDO), and Functional Genomic and Computational Assessment of Threats (Fun GCAT) are among the significant primary and secondary sources for pharmaceutical continuous manufacturing included in the report others.

Table of Contents

1. Introduction
1.1 Study Scope
1.2 Report Guidance
1.3 Market Segmentation
1.3.1 Europe Pharmaceutical Continuous Manufacturing Market - By Product
1.3.2 Europe Pharmaceutical Continuous Manufacturing Market - By Application
1.3.3 Europe Pharmaceutical Continuous Manufacturing Market - By End User
1.3.4 Europe Pharmaceutical Continuous Manufacturing Market - By Country
2. Europe Pharmaceutical Continuous Manufacturing Market - Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Europe Pharmaceutical Continuous Manufacturing Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 Europe Pharmaceutical Continuous Manufacturing Market - Europe PEST Analysis
4.3 Expert Opinion
5. Europe Pharmaceutical Continuous Manufacturing - Key Market Dynamics
5.1 Key Market Drivers
5.1.1 Increasing Shortage of Medicines
5.2 Key Restraints
5.2.1 High Cost Involved in Drug Manufacturing
5.3 Key Market Opportunities
5.3.1 Strategic Activities by the Manufacturers
5.4 Future Trend
5.4.1 Increasing Adoption of Continuous Manufacturing in Pharmaceuticals
5.5 Impact Analysis
6. Pharmaceutical Continuous Manufacturing Market - Europe Analysis
6.1 Europe Pharmaceutical Continuous Manufacturing Market Revenue Forecasts and Analysis
7. Pharmaceutical Continuous Manufacturing Market Analysis - By Product
7.1 Overview
7.2 Pharmaceutical Continuous Manufacturing Market Share, by Product, 2019 and 2027 (%)
7.3 Integrated Systems
7.3.1 Overview
7.3.2 Integrated Systems: Pharmaceutical Continuous Manufacturing Market- Revenue and Forecast to 2027 (US$ Million)
7.4 Semi-Continuous Systems
7.4.1 Overview
7.4.2 Semi-Continuous Systems: Pharmaceutical Continuous Manufacturing Market- Revenue and Forecast to 2027 (US$ Million)
7.4.3 Continuous Granulators
7.4.3.1 Overview
7.4.3.2 Continuous Granulators: Pharmaceutical Continuous Manufacturing Market- Revenue and Forecast to 2027 (US$ Million)
7.4.4 Continuous Blenders
7.4.4.1 Overview
7.4.4.2 Continuous Blenders: Pharmaceutical Continuous Manufacturing Market- Revenue and Forecast to 2027 (US$ Million)
7.4.5 Continuous Compressors
7.4.5.1 Overview
7.4.5.2 Continuous Compressors: Pharmaceutical Continuous Manufacturing Market- Revenue and Forecast to 2027 (US$ Million)
7.4.6 Continuous Coaters
7.4.6.1 Overview
7.4.6.2 Continuous Coaters: Pharmaceutical Continuous Manufacturing Market- Revenue and Forecast to 2027 (US$ Million)
7.4.7 Continuous Dryers
7.4.7.1 Overview
7.4.7.2 Continuous Dryers: Pharmaceutical Continuous Manufacturing Market- Revenue and Forecast to 2027 (US$ Million)
7.4.8 Other Semi-Continuous Systems
7.4.8.1 Overview
7.4.8.2 Other Semi-Continuous Systems: Pharmaceutical Continuous Manufacturing Market- Revenue and Forecast to 2027 (US$ Million)
7.5 Controls
7.5.1 Overview
7.5.2 Controls: Pharmaceutical Continuous Manufacturing Market- Revenue and Forecast to 2027 (US$ Million)
8. Pharmaceutical Continuous Manufacturing Market- By Application
8.1 Overview
8.2 Pharmaceutical Continuous Manufacturing Market Share, by Application, 2019 and 2027 (%)
8.3 End Product Manufacturing
8.3.1 Overview
8.3.2 End Product Manufacturing: Pharmaceutical Continuous Manufacturing Market- Revenue and Forecast to 2027 (US$ million)
8.3.3 Solid Dosage Manufacturing
8.3.3.1 Overview
8.3.3.2 Solid Dosage Manufacturing: Pharmaceutical Continuous Manufacturing Market- Revenue and Forecast to 2027 (US$ million)
8.3.4 Liquid Dosage Manufacturing
8.3.4.1 Overview
8.3.4.2 Liquid Dosage Manufacturing: Pharmaceutical Continuous Manufacturing Market- Revenue and Forecast to 2027 (US$ million)
8.4 API Manufacturing
8.4.1 Overview
8.4.2 API Manufacturing: Pharmaceutical Continuous Manufacturing Market- Revenue and Forecast to 2027 (US$ million)
9. Pharmaceutical Continuous Manufacturing Market - By End User
9.1 Overview
9.2 Pharmaceutical Continuous Manufacturing Market Share, by End User, 2019 and 2027 (%)
9.3 Full-Scale Manufacturing Companies
9.3.1 Overview
9.3.2 Full-Scale Manufacturing Companies: Pharmaceutical Continuous Manufacturing Market- Revenue and Forecast to 2027 (US$ million)
9.3.3 Pharmaceutical Companies
9.3.3.1 Overview
9.3.3.2 Pharmaceutical Companies: Pharmaceutical Continuous Manufacturing Market- Revenue and Forecast to 2027 (US$ million)
9.3.4 Contract Manufacturing Organizations
9.3.4.1 Overview
9.3.4.2 Contract Manufacturing Organizations: Pharmaceutical Continuous Manufacturing Market- Revenue and Forecast to 2027 (US$ million)
9.4 R&D Departments
9.4.1 Overview
9.4.2 R&D Departments: Pharmaceutical Continuous Manufacturing Market- Revenue and Forecast to 2027 (US$ million)
9.4.3 Contract Research Organizations
9.4.3.1 Overview
9.4.3.2 Contract Research Organizations: Pharmaceutical Continuous Manufacturing Market- Revenue and Forecast to 2027 (US$ million)
9.4.4 Research Institutes
9.4.4.1 Overview
9.4.4.2 Research Institutes: Pharmaceutical Continuous Manufacturing Market- Revenue and Forecast to 2027 (US$ million)
10. Pharmaceutical Continuous Manufacturing Market Revenue and Forecasts To 2027 - Geographical Analysis
10.1 Europe Pharmaceutical Continuous Manufacturing Market Revenue and Forecasts To 2027
10.1.1 Overview
10.1.2 Europe: Pharmaceutical Continuous Manufacturing Market - Revenue and Forecast to 2027 (USD Million)
10.1.3 Europe: Pharmaceutical Continuous Manufacturing Market, by Product, 2018-2027 (USD Million)
10.1.3.1 Europe: Semi-Continuous Systems Market, by Type, 2018-2027 (USD Million)
10.1.4 Europe: Pharmaceutical Continuous Manufacturing Market, by Application, 2018-2027 (USD Million)
10.1.4.1 Europe: End Product Manufacturing Market, by Type, 2018-2027 (USD Million)
10.1.5 Europe: Pharmaceutical Continuous Manufacturing Market, by End User, 2018-2027 (USD Million)
10.1.5.1 Europe: Full-Scale Manufacturing Companies Market, by Type, 2018-2027 (USD Million)
10.1.5.2 Europe: R&D Departments Market, by Type, 2018-2027 (USD Million)
10.1.6 Europe: Pharmaceutical Continuous Manufacturing Market, by Country, 2018 & 2027 (%)
10.1.7 Germany: Pharmaceutical Continuous Manufacturing Market - Revenue and Forecast to 2027 (USD Million)
10.1.7.1 Germany: Pharmaceutical Continuous Manufacturing Market - Revenue and Forecast to 2027 (USD Million)
10.1.7.2 Germany: Pharmaceutical Continuous Manufacturing Market, by Product, 2018-2027 (USD Million)
10.1.7.2.1 Germany: Semi-Continuous Systems Market, by Type, 2018-2027 (USD Million)
10.1.7.3 Germany: Pharmaceutical Continuous Manufacturing Market, by Application, 2018-2027 (USD Million)
10.1.7.3.1 Germany: End Product Manufacturing Market, by Type, 2018-2027 (USD Million)
10.1.7.4 Germany: Pharmaceutical Continuous Manufacturing Market, by End User, 2018-2027 (USD Million)
10.1.7.4.1 Germany: Full-Scale Manufacturing Companies Market, by Type, 2018-2027 (USD Million)
10.1.7.4.2 Germany: R&D Departments Market, by Type, 2018-2027 (USD Million)
10.1.8 UK: Pharmaceutical Continuous Manufacturing Market - Revenue and Forecast to 2027 (USD Million)
10.1.8.1 UK: Pharmaceutical Continuous Manufacturing Market - Revenue and Forecast to 2027 (USD Million)
10.1.8.2 UK: Pharmaceutical Continuous Manufacturing Market, by Product, 2018-2027 (USD Million)
10.1.8.2.1 UK: Semi-Continuous Systems Market, by Type, 2018-2027 (USD Million)
10.1.8.3 UK: Pharmaceutical Continuous Manufacturing Market, by Application, 2018-2027 (USD Million)
10.1.8.3.1 UK: End Product Manufacturing Market, by Type, 2018-2027 (USD Million)
10.1.8.4 UK: Pharmaceutical Continuous Manufacturing Market, by End User, 2018-2027 (USD Million)
10.1.8.4.1 UK: Full-Scale Manufacturing Companies Market, by Type, 2018-2027 (USD Million)
10.1.8.4.2 UK: R&D Departments Market, by Type, 2018-2027 (USD Million)
10.1.9 France: Pharmaceutical Continuous Manufacturing Market - Revenue and Forecast to 2027 (USD Million)
10.1.9.1 France: Pharmaceutical Continuous Manufacturing Market - Revenue and Forecast to 2027 (USD Million)
10.1.9.2 France: Pharmaceutical Continuous Manufacturing Market, by Product, 2018-2027 (USD Million)
10.1.9.2.1 France: Semi-Continuous Systems Market, by Type, 2018-2027 (USD Million)
10.1.9.3 France: Pharmaceutical Continuous Manufacturing Market, by Application, 2018-2027 (USD Million)
10.1.9.3.1 France: End Product Manufacturing Market, by Type, 2018-2027 (USD Million)
10.1.9.4 France: Pharmaceutical Continuous Manufacturing Market, by End User, 2018-2027 (USD Million)
10.1.9.4.1 France: Full-Scale Manufacturing Companies Market, by Type, 2018-2027 (USD Million)
10.1.9.4.2 France: R&D Departments Market, by Type, 2018-2027 (USD Million)
10.1.10 Spain: Pharmaceutical Continuous Manufacturing Market - Revenue and Forecast to 2027 (USD Million)
10.1.10.1 Spain: Pharmaceutical Continuous Manufacturing Market - Revenue and Forecast to 2027 (USD Million)
10.1.10.2 Spain: Pharmaceutical Continuous Manufacturing Market, by Product, 2018-2027 (USD Million)
10.1.10.2.1 Spain: Semi-Continuous Systems Market, by Type, 2018-2027 (USD Million)
10.1.10.3 Spain: Pharmaceutical Continuous Manufacturing Market, by Application, 2018-2027 (USD Million)
10.1.10.3.1 Spain: End Product Manufacturing Market, by Type, 2018-2027 (USD Million)
10.1.10.4 Spain: Pharmaceutical Continuous Manufacturing Market, by End User, 2018-2027 (USD Million)
10.1.10.4.1 Spain: Full-Scale Manufacturing Companies Market, by Type, 2018-2027 (USD Million)
10.1.10.4.2 Spain: R&D Departments Market, by Type, 2018-2027 (USD Million)
10.1.11 Italy: Pharmaceutical Continuous Manufacturing Market - Revenue and Forecast to 2027 (USD Million)
10.1.11.1 Italy: Pharmaceutical Continuous Manufacturing Market - Revenue and Forecast to 2027 (USD Million)
10.1.11.2 Italy: Pharmaceutical Continuous Manufacturing Market, by Product, 2018-2027 (USD Million)
10.1.11.2.1 Italy: Semi-Continuous Systems Market, by Type, 2018-2027 (USD Million)
10.1.11.3 Italy: Pharmaceutical Continuous Manufacturing Market, by Application, 2018-2027 (USD Million)
10.1.11.3.1 Italy: End Product Manufacturing Market, by Type, 2018-2027 (USD Million)
10.1.11.4 Italy: Pharmaceutical Continuous Manufacturing Market, by End User, 2018-2027 (USD Million)
10.1.11.4.1 Italy: Full-Scale Manufacturing Companies Market, by Type, 2018-2027 (USD Million)
10.1.11.4.2 Italy: R&D Departments Market, by Type, 2018-2027 (USD Million)
11. Impact of COVID-19 Pandemic on Global Pharmaceutical Continuous Manufacturing Market
11.1 Europe: Impact Assessment of COVID-19 Pandemic
12. Company Profiles
12.1 KORSCH AG
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 LEISTRITZ AG
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 ALEXANDERWERK AG
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 Hovione
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 Fette Compacting
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
13. Appendix
13.1 About the Publisher
13.2 Glossary of Terms
List of Tables
Table 1. Europe Pharmaceutical Continuous Manufacturing Market, by Product– Revenue and Forecast to 2027 (USD Million)
Table 2. Europe: Semi-Continuous Systems Market, by Type– Revenue and Forecast to 2027 (USD Million)
Table 3. Europe: Pharmaceutical Continuous Manufacturing Market, by Application – Revenue and Forecast to 2027 (USD Million)
Table 4. Europe: End Product Manufacturing Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 5. Europe: Pharmaceutical Continuous Manufacturing Market, by End User – Revenue and Forecast to 2027 (USD Million)
Table 6. Europe: Full-Scale Manufacturing Companies Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 7. Europe: R&D Departments Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 8. Germany: Pharmaceutical Continuous Manufacturing Market, by Product– Revenue and Forecast to 2027 (USD Million)
Table 9. Germany: Semi-Continuous Systems Market, by Type– Revenue and Forecast to 2027 (USD Million)
Table 10. Germany: Pharmaceutical Continuous Manufacturing Market, by Application – Revenue and Forecast to 2027 (USD Million)
Table 11. Germany: End Product Manufacturing Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 12. Germany: Pharmaceutical Continuous Manufacturing Market, by End User – Revenue and Forecast to 2027 (USD Million)
Table 13. Germany: Full-Scale Manufacturing Companies Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 14. Germany: R&D Departments Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 15. UK: Pharmaceutical Continuous Manufacturing Market, by Product– Revenue and Forecast to 2027 (USD Million)
Table 16. UK: Semi-Continuous Systems Market, by Type– Revenue and Forecast to 2027 (USD Million)
Table 17. UK: Pharmaceutical Continuous Manufacturing Market, by Application – Revenue and Forecast to 2027 (USD Million)
Table 18. UK: End Product Manufacturing Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 19. UK: Pharmaceutical Continuous Manufacturing Market, by End User – Revenue and Forecast to 2027 (USD Million)
Table 20. UK: Full-Scale Manufacturing Companies Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 21. UK: R&D Departments Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 22. France: Pharmaceutical Continuous Manufacturing Market, by Product– Revenue and Forecast to 2027 (USD Million)
Table 23. France: Semi-Continuous Systems Market, by Type– Revenue and Forecast to 2027 (USD Million)
Table 24. France: Pharmaceutical Continuous Manufacturing Market, by Application – Revenue and Forecast to 2027 (USD Million)
Table 25. France: End Product Manufacturing Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 26. France: Pharmaceutical Continuous Manufacturing Market, by End User – Revenue and Forecast to 2027 (USD Million)
Table 27. France: Full-Scale Manufacturing Companies Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 28. France: R&D Departments Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 29. Spain: Pharmaceutical Continuous Manufacturing Market, by Product– Revenue and Forecast to 2027 (USD Million)
Table 30. Spain: Semi-Continuous Systems Market, by Type– Revenue and Forecast to 2027 (USD Million)
Table 31. Spain: Pharmaceutical Continuous Manufacturing Market, by Application – Revenue and Forecast to 2027 (USD Million)
Table 32. Spain: End Product Manufacturing Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 33. Spain: Pharmaceutical Continuous Manufacturing Market, by End User – Revenue and Forecast to 2027 (USD Million)
Table 34. Spain: Full-Scale Manufacturing Companies Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 35. Spain: R&D Departments Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 36. Italy: Pharmaceutical Continuous Manufacturing Market, by Product– Revenue and Forecast to 2027 (USD Million)
Table 37. Italy: Semi-Continuous Systems Market, by Type– Revenue and Forecast to 2027 (USD Million)
Table 38. Italy: Pharmaceutical Continuous Manufacturing Market, by Application – Revenue and Forecast to 2027 (USD Million)
Table 39. Italy: End Product Manufacturing Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 40. Italy: Pharmaceutical Continuous Manufacturing Market, by End User – Revenue and Forecast to 2027 (USD Million)
Table 41. Italy: Full-Scale Manufacturing Companies Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 42. Italy: R&D Departments Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 43. Glossary of Terms, Europe Pharmaceutical Continuous Manufacturing Market
List of Figures
Figure 1. Pharmaceutical Continuous Manufacturing Market Segmentation
Figure 2. Europe Pharmaceutical Continuous Manufacturing Market Overview
Figure 3. The Integrated Systems Segment Held Largest Share of Product Segment in Pharmaceutical Continuous Manufacturing Market
Figure 4. Germany Is Expected to Show Remarkable Growth During the Forecast Period
Figure 5. Europe Pharmaceutical Continuous Manufacturing Market- Leading Country Markets (US$ Mn)
Figure 6. Europe Pharmaceutical Continuous Manufacturing Market - Europe PEST Analysis
Figure 7. Pharmaceutical Continuous Manufacturing Market Impact Analysis of Drivers and Restraints
Figure 8. Europe Pharmaceutical Continuous Manufacturing Market – Revenue Forecasts and Analysis – 2019- 2027
Figure 9. Pharmaceutical Continuous Manufacturing Market Share, by Product, 2019 and 2027 (%)
Figure 10. Integrated Systems: Pharmaceutical Continuous Manufacturing Market– Revenue and Forecast to 2027 (US$ Million)
Figure 11. Semi-Continuous Systems: Pharmaceutical Continuous Manufacturing Market– Revenue and Forecast to 2027 (US$ Million)
Figure 12. Continuous Granulators: Pharmaceutical Continuous Manufacturing Market– Revenue and Forecast to 2027 (US$ Million)
Figure 13. Continuous Blenders: Pharmaceutical Continuous Manufacturing Market– Revenue and Forecast to 2027 (US$ Million)
Figure 14. Continuous Compressors: Pharmaceutical Continuous Manufacturing Market– Revenue and Forecast to 2027 (US$ Million)
Figure 15. Continuous Coaters: Pharmaceutical Continuous Manufacturing Market– Revenue and Forecast to 2027 (US$ Million)
Figure 16. Continuous Dryers: Pharmaceutical Continuous Manufacturing Market– Revenue and Forecast to 2027 (US$ Million)
Figure 17. Other Semi-Continuous Systems: Pharmaceutical Continuous Manufacturing Market– Revenue and Forecast to 2027 (US$ Million)
Figure 18. Controls: Pharmaceutical Continuous Manufacturing Market– Revenue and Forecast to 2027 (US$ Million)
Figure 19. Pharmaceutical Continuous Manufacturing Market Share, by Application, 2019 and 2027 (%)
Figure 20. End Product Manufacturing: Pharmaceutical Continuous Manufacturing Market– Revenue and Forecast to 2027 (US$ million)
Figure 21. Solid Dosage Manufacturing: Pharmaceutical Continuous Manufacturing Market– Revenue and Forecast to 2027 (US$ million)
Figure 22. Liquid Dosage Manufacturing: Pharmaceutical Continuous Manufacturing Market– Revenue and Forecast to 2027 (US$ million)
Figure 23. API Manufacturing: Pharmaceutical Continuous Manufacturing Market– Revenue and Forecast to 2027 (US$ million)
Figure 24. Pharmaceutical Continuous Manufacturing Market Share, by End User, 2019 and 2027 (%)
Figure 25. Full-Scale Manufacturing Companies: Pharmaceutical Continuous Manufacturing Market– Revenue and Forecast to 2027 (US$ million)
Figure 26. Pharmaceutical Companies: Pharmaceutical Continuous Manufacturing Market– Revenue and Forecast to 2027 (US$ million)
Figure 27. Contract Manufacturing Organizations: Pharmaceutical Continuous Manufacturing Market– Revenue and Forecast to 2027 (US$ million)
Figure 28. R&D Departments: Pharmaceutical Continuous Manufacturing Market– Revenue and Forecast to 2027 (US$ million)
Figure 29. Contract Research Organizations: Pharmaceutical Continuous Manufacturing Market– Revenue and Forecast to 2027 (US$ million)
Figure 30. Research Institutes: Pharmaceutical Continuous Manufacturing Market– Revenue and Forecast to 2027 (US$ million)
Figure 31. Europe: Pharmaceutical Continuous Manufacturing Market, by Key Country – Revenue (2019) (USD Million)
Figure 32. Europe Pharmaceutical Continuous Manufacturing Market Revenue and Forecast to 2027 (USD Million)
Figure 33. Europe: Pharmaceutical Continuous Manufacturing Market, by Country, 2018 & 2027 (%)
Figure 34. Germany: Pharmaceutical Continuous Manufacturing Market – Revenue and Forecast to 2027 (USD Million)
Figure 35. UK: Pharmaceutical Continuous Manufacturing Market – Revenue and Forecast to 2027 (USD Million)
Figure 36. France: Pharmaceutical Continuous Manufacturing Market – Revenue and Forecast to 2027 (USD Million)
Figure 37. Spain: Pharmaceutical Continuous Manufacturing Market – Revenue and Forecast to 2027 (USD Million)
Figure 38. Italy: Pharmaceutical Continuous Manufacturing Market – Revenue and Forecast to 2027 (USD Million)
Figure 39. Impact of COVID-19 Pandemic in Europe Country Markets

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Fette Compacting
  • KORSCH AG
  • LEISTRITZ AG
  • ALEXANDERWERK AG
  • Hovione

Related Topics

Related Reports

Global Pharmaceutical Continuous Manufacturing Market by Product (Integrated Systems, Semi-Continuous Systems), Distribution (Hospital Pharmacy, Online Pharmacy, Retail Pharmacy), Application, End User - Forecast 2024-2030 - Product Image

Global Pharmaceutical Continuous Manufacturing Market by Product (Integrated Systems, Semi-Continuous Systems), Distribution (Hospital Pharmacy, Online Pharmacy, Retail Pharmacy), Application, End User - Forecast 2024-2030

  • Report
  • 186 Pages
  • Global
From
Pharmaceutical Continuous Manufacturing Global Market Report 2024 - Product Image

Pharmaceutical Continuous Manufacturing Global Market Report 2024

  • Report
  • 175 Pages
  • Global
From
Pharmaceutical Continuous Manufacturing Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028 - Product Image

Pharmaceutical Continuous Manufacturing Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028

  • Report
  • 148 Pages
  • Global
From
Global Pharmaceutical Continuous Manufacturing Market 2024-2028 - Product Image

Global Pharmaceutical Continuous Manufacturing Market 2024-2028

  • Report
  • 171 Pages
  • Global
From
Pharmaceutical Continuous Manufacturing Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type - Product Image

Pharmaceutical Continuous Manufacturing Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type

  • Report
  • 97 Pages
  • Global
From
Copyright © 2002-2024 Research and Markets. All Rights Reserved.